This allows for synthetic mRNAs to be used to restore otherwise absent proteins in disease, as evidenced by the use of this approach in protein replacement therapies, such as mRNA encoding the cystic fibrosis transmembrane conductance regulator protein in cystic fibrosis.83 Here, CFTR is linked to cystic fibrosis.